129 related articles for article (PubMed ID: 38552478)
1. High-throughput BCRP inhibitors screening system based on styrene maleic acid polymer membrane protein stabilization strategy and surface plasmon resonance biosensor.
Fang J; Shen S; Wang H; He Y; Chao L; Cao Y; Chen X; Zhu Z; Hong Z; Chai Y
Talanta; 2024 Jul; 274():125987. PubMed ID: 38552478
[TBL] [Abstract][Full Text] [Related]
2. Screening potential P-glycoprotein inhibitors by combination of a detergent-free membrane protein extraction with surface plasmon resonance biosensor.
Cao Y; Fang J; Shi Y; Wang H; Chen X; Liu Y; Zhu Z; Cao Y; Hong Z; Chai Y
Acta Pharm Sin B; 2022 Jul; 12(7):3113-3123. PubMed ID: 35865104
[TBL] [Abstract][Full Text] [Related]
3. Surface plasmon resonance biosensor combined with lentiviral particle stabilization strategy for rapid and specific screening of P-Glycoprotein ligands.
Cao Y; Cao Y; Shi Y; Cai Y; Chen L; Wang D; Liu Y; Chen X; Zhu Z; Hong Z; Chai Y
Anal Bioanal Chem; 2021 Mar; 413(7):2021-2031. PubMed ID: 33528601
[TBL] [Abstract][Full Text] [Related]
4. Interactions of the major effective components in Shengmai formula with breast cancer resistance protein at the cellular and vesicular levels.
Wu L; Liu J; Hou J; Zhan T; Yuan L; Liu F; Xiong Y; Hu J; Xia C
Biomed Pharmacother; 2021 Jan; 133():110939. PubMed ID: 33232930
[TBL] [Abstract][Full Text] [Related]
5. The Impact of Endogenous Breast Cancer Resistance Protein on Human P-Glycoprotein-Mediated Transport Assays Using LLC-PK1 Cells Transfected With Human P-Glycoprotein.
Miyamoto R; Nozawa T; Shiozuka K; Tabata K
J Pharm Sci; 2019 Mar; 108(3):1085-1089. PubMed ID: 30339864
[TBL] [Abstract][Full Text] [Related]
6. [Establishment of BCRP expressed pig kidney cell line LLC-PK1/BCRP and its biological profile].
Tian Y; Qu BX; Yao Y; Zeng S
Yao Xue Xue Bao; 2012 Dec; 47(12):1599-604. PubMed ID: 23460964
[TBL] [Abstract][Full Text] [Related]
7. Breast cancer resistance protein exports sulfated estrogens but not free estrogens.
Imai Y; Asada S; Tsukahara S; Ishikawa E; Tsuruo T; Sugimoto Y
Mol Pharmacol; 2003 Sep; 64(3):610-8. PubMed ID: 12920197
[TBL] [Abstract][Full Text] [Related]
8. Development of Styrene Maleic Acid Lipid Particles as a Tool for Studies of Phage-Host Interactions.
de Jonge PA; Smit Sibinga DJC; Boright OA; Costa AR; Nobrega FL; Brouns SJJ; Dutilh BE
J Virol; 2020 Nov; 94(23):. PubMed ID: 32938760
[TBL] [Abstract][Full Text] [Related]
9. A comparison of SMA (styrene maleic acid) and DIBMA (di-isobutylene maleic acid) for membrane protein purification.
Gulamhussein AA; Uddin R; Tighe BJ; Poyner DR; Rothnie AJ
Biochim Biophys Acta Biomembr; 2020 Jul; 1862(7):183281. PubMed ID: 32209303
[TBL] [Abstract][Full Text] [Related]
10. Conformational trapping of an ABC transporter in polymer lipid nanoparticles.
Pollock NL; Lloyd J; Montinaro C; Rai M; Dafforn TR
Biochem J; 2022 Jan; 479(2):145-159. PubMed ID: 35050326
[TBL] [Abstract][Full Text] [Related]
11. Structural characterization of styrene-maleic acid copolymer-lipid nanoparticles (SMALPs) using EPR spectroscopy.
Bali AP; Sahu ID; Craig AF; Clark EE; Burridge KM; Dolan MT; Dabney-Smith C; Konkolewicz D; Lorigan GA
Chem Phys Lipids; 2019 May; 220():6-13. PubMed ID: 30796886
[TBL] [Abstract][Full Text] [Related]
12. TKI combination therapy: strategy to enhance dasatinib uptake by inhibiting Pgp- and BCRP-mediated efflux.
D'Cunha R; Bae S; Murry DJ; An G
Biopharm Drug Dispos; 2016 Oct; 37(7):397-408. PubMed ID: 27418107
[TBL] [Abstract][Full Text] [Related]
13. Styrene/Maleic Acid Copolymers Form SMALPs by Pulling Lipid Patches out of the Lipid Bilayer.
Orekhov PS; Bozdaganyan ME; Voskoboynikova N; Mulkidjanian AY; Steinhoff HJ; Shaitan KV
Langmuir; 2019 Mar; 35(10):3748-3758. PubMed ID: 30773011
[TBL] [Abstract][Full Text] [Related]
14. Detergent-free purification of ABC (ATP-binding-cassette) transporters.
Gulati S; Jamshad M; Knowles TJ; Morrison KA; Downing R; Cant N; Collins R; Koenderink JB; Ford RC; Overduin M; Kerr ID; Dafforn TR; Rothnie AJ
Biochem J; 2014 Jul; 461(2):269-78. PubMed ID: 24758594
[TBL] [Abstract][Full Text] [Related]
15. Flavonoids are inhibitors of breast cancer resistance protein (ABCG2)-mediated transport.
Zhang S; Yang X; Morris ME
Mol Pharmacol; 2004 May; 65(5):1208-16. PubMed ID: 15102949
[TBL] [Abstract][Full Text] [Related]
16. Phytoestrogens/flavonoids reverse breast cancer resistance protein/ABCG2-mediated multidrug resistance.
Imai Y; Tsukahara S; Asada S; Sugimoto Y
Cancer Res; 2004 Jun; 64(12):4346-52. PubMed ID: 15205350
[TBL] [Abstract][Full Text] [Related]
17. The PI3K subunits, P110α and P110β are potential targets for overcoming P-gp and BCRP-mediated MDR in cancer.
Zhang L; Li Y; Wang Q; Chen Z; Li X; Wu Z; Hu C; Liao D; Zhang W; Chen ZS
Mol Cancer; 2020 Jan; 19(1):10. PubMed ID: 31952518
[TBL] [Abstract][Full Text] [Related]
18. Kinetic analysis of antibody binding to integral membrane proteins stabilized in SMALPs.
Sharma P; Plant M; Lam SK; Chen Q
BBA Adv; 2021; 1():100022. PubMed ID: 37082021
[TBL] [Abstract][Full Text] [Related]
19. Synthesis of 5-Hydroxy-3',4',7-trimethoxyflavone and Related Compounds and Elucidation of Their Reversal Effects on BCRP/ABCG2-Mediated Anticancer Drug Resistance.
Tsunekawa R; Katayama K; Hanaya K; Higashibayashi S; Sugimoto Y; Sugai T
Chembiochem; 2019 Jan; 20(2):210-220. PubMed ID: 30187992
[TBL] [Abstract][Full Text] [Related]
20. Immunochemical characterisation of styrene maleic acid lipid particles prepared from Mycobacterium tuberculosis plasma membrane.
Sinha S; Kumar S; Singh K; Umam F; Agrawal V; Aggarwal A; Imperiali B
PLoS One; 2023; 18(1):e0280074. PubMed ID: 36608027
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
